中文
From June 16th to 18th, 2026, CPHI China Shanghai World Pharmaceutical Raw Materials Exhibition will be held grandly at the Shanghai New International Expo Center (Pudong). As a highly influential global professional exhibition in the pharmaceutical and chemical industry, this exhibition gathers resources from the entire industry chain of raw materials, pharmaceutical intermediates, fine chemicals, and biopharmaceuticals at home and abroad. Nanjing Shunxiang Pharmaceutical Technology Co., Ltd. cordially invites customers and industry colleagues from home and abroad to visit our booth for cooperation and market expansion!
Nanjing Shunxiang Pharmaceutical Technology Co., Ltd. has been deeply involved in the field of pharmaceutical chemical intermediates for many years. It is a production-oriented enterprise that integrates research and development, production, sales, and technical services. With stable production capacity, excellent quality, and efficient service, it has gained recognition from customers. For this exhibition, we will bring multiple core products: diisopropyl azodicarboxylate (DIAD), di tert butyl azodicarboxylate (DBAD), di tert butyl dicarbonate (Di Boc), pyridinium p-toluenesulfonate (PPTS), pyridinium trioxide (PST), and pyridinium tribromide (PHBP). Fully showcase our development history, production capacity advantages, and technological strength.
During the exhibition, the technical and sales teams will be stationed at booth E11C56 to provide one-on-one answers on product parameters, production capacity scheduling, customized development, cooperation models, and other issues, accurately matching various procurement and research and development needs. We look forward to colleagues from all walks of life coming to visit and guide us, and have in-depth exchanges on industry technical difficulties and market development pain points.
Take exhibition as a bridge, gather strength for mutual benefit. Shunxiang Pharmaceutical sincerely looks forward to meeting with you in Shanghai for face-to-face negotiations, in-depth cooperation, and jointly exploring new blue oceans in the pharmaceutical industry!